Nomura Research Institute, Ltd.
Nomura Research Institute, Ltd. Fundamental Analysis
Nomura Research Institute, Ltd. (4307.T) shows moderate financial fundamentals with a PE ratio of 23.47, profit margin of 13.16%, and ROE of 22.66%. The company generates $798.8B in annual revenue with moderate year-over-year growth of 3.84%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 4307.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent4307.T demonstrates superior asset utilization.
Valuation Score
Moderate4307.T shows balanced valuation metrics.
Growth Score
Moderate4307.T shows steady but slowing expansion.
Financial Health Score
Excellent4307.T maintains a strong and stable balance sheet.
Profitability Score
Moderate4307.T maintains healthy but balanced margins.
Key Financial Metrics
Is 4307.T Expensive or Cheap?
P/E Ratio
4307.T trades at 23.47 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 4307.T's PEG of 7.00 indicates potential overvaluation.
Price to Book
The market values Nomura Research Institute, Ltd. at 4.92 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 11.55 times EBITDA. This signals the market has high growth expectations.
How Well Does 4307.T Make Money?
Net Profit Margin
For every $100 in sales, Nomura Research Institute, Ltd. keeps $13.16 as profit after all expenses.
Operating Margin
Core operations generate 18.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.66 in profit for every $100 of shareholder equity.
ROA
Nomura Research Institute, Ltd. generates $11.09 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Nomura Research Institute, Ltd. produces operating cash flow of $143.40B, showing steady but balanced cash generation.
Free Cash Flow
Nomura Research Institute, Ltd. generates strong free cash flow of $137.89B, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $240.51 in free cash annually.
FCF Yield
4307.T converts 5.59% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
23.47
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
7.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.92
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.47
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.08
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.23
vs 25 benchmark
ROA
Return on assets percentage
0.11
vs 25 benchmark
ROCE
Return on capital employed
0.19
vs 25 benchmark
How 4307.T Stacks Against Its Sector Peers
| Metric | 4307.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 23.47 | 34.43 | Better (Cheaper) |
| ROE | 22.66% | 1135.00% | Weak |
| Net Margin | 13.16% | -134663.00% (disorted) | Strong |
| Debt/Equity | 0.47 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 2.08 | 5.77 | Strong Liquidity |
| ROA | 11.09% | -310462.00% (disorted) | Strong |
4307.T outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Nomura Research Institute, Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
59.82%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
78.06%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
39.99%
Industry Style: Growth, Innovation, High Beta
High Growth